Belgium’s Solvay was in focus amid talk that a large European drugmaker was running its tape measure over the chemicals and pharmaceuticals group. Its shares rose 4.9 per cent while the FTSE Eurofirst 300 Pharmaceutical and Biotechnology index gained 2.9 per cent